Tetherin restricts HSV-2 release and is counteracted by multiple viral glycoproteins

被引:25
|
作者
Liu, Yalan [1 ]
Luo, Sukun [1 ,2 ]
He, Siyi [1 ,2 ]
Zhang, Mudan [1 ,2 ]
Wang, Ping [1 ,2 ]
Li, Chang [1 ,2 ]
Huang, Wenjie [1 ]
Hu, Bodan [1 ,2 ]
Griffin, George E. [3 ]
Shattock, Robin J. [4 ]
Hu, Qinxue [1 ,3 ]
机构
[1] Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan 430071, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[3] St Georges Univ London, Inst Infect & Immun, London SW17 0RE, England
[4] Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, Fac Med, London W2 1PG, England
基金
中国国家自然科学基金;
关键词
HSV-2; Tetherin; Viral release; Viral glycoprotein; HERPES-SIMPLEX-VIRUS; DOWN-REGULATION; HIV-1; RELEASE; CELL-SURFACE; PROTEIN; EXPRESSION; INFECTION; VPU; COMPLEX; TYPE-1;
D O I
10.1016/j.virol.2014.11.005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Tetherin has been defined as a restriction factor of HIV-1 and several other enveloped viruses. However, the significance of tetherin in viral infection remains to be further addressed. Here, we investigated whether tetherin plays a role in HSV-2 infection. Our study revealed that overexpression of tetherin restricted the release of HSV-2 into the extracellular medium, while knockdown of tetherin by siRNA enhanced its release. We further demonstrated that HSV-2 infection and viral glycoproteins gB, gD, gH and gL but not gM significantly downregulated the endogenous expression of tetherin. Additional study indicated that tetherin likely physically interacted with gB, gD, gH and gL. This is the first time that tetherin has been shown to be counteracted by multiple viral components of a virus. Our findings inform the complexity of HSV-2-host interactions, providing basis for understanding the role of tetherin as a viral restriction factor and the mechanisms underlying viral countermeasures. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:96 / 109
页数:14
相关论文
共 50 条
  • [21] HUMORAL IMMUNE-RESPONSE TO HSV-1 AND HSV-2 VIRAL-PROTEINS IN PATIENTS WITH PRIMARY GENITAL HERPES
    ASHLEY, R
    BENEDETTI, J
    COREY, L
    JOURNAL OF MEDICAL VIROLOGY, 1985, 17 (02) : 153 - 166
  • [22] Development of a Glycoprotein D-Expressing Dominant-Negative and Replication-Defective Herpes Simplex Virus 2 (HSV-2) Recombinant Viral Vaccine against HSV-2 Infection in Mice
    Akhrameyeva, Natalie V.
    Zhang, Pengwei
    Sugiyama, Nao
    Behar, Samuel M.
    Yao, Feng
    JOURNAL OF VIROLOGY, 2011, 85 (10) : 5036 - 5047
  • [23] DIFFERENCES BETWEEN HSV-1 AND HSV-2 IN THE ROLE OF GLYCOPROTEIN C (GC) IN VIRAL ENTRY MAY EXPLAIN DIFFERENCES IN TROPISM
    GERBER, SI
    BELVAL, B
    HEROLD, BC
    PEDIATRIC RESEARCH, 1995, 37 (04) : A175 - A175
  • [25] BST-2 restricts IAV release and is countered by the viral M2 protein
    Hu, Siqi
    Yin, Lijuan
    Mei, Shan
    Li, Jian
    Xu, Fengwen
    Sun, Hong
    Liu, Xiaoman
    Cen, Shan
    Liang, Chen
    Li, Ailing
    Guo, Fei
    BIOCHEMICAL JOURNAL, 2017, 474 : 715 - 730
  • [26] Herpes Simplex Virus Mistyping due to HSV-1 x HSV-2 Interspecies Recombination in Viral Gene Encoding Glycoprotein B
    Casto, Amanda M.
    Huang, Meei-Li W.
    Xie, Hong
    Jerome, Keith R.
    Wald, Anna
    Johnston, Christine M.
    Greninger, Alexander L.
    VIRUSES-BASEL, 2020, 12 (08):
  • [27] DIFFERENCES IN THE ROLE OF GLYCOPROTEIN-C OF HSV-1 AND HSV-2 IN VIRAL BINDING MAY CONTRIBUTE TO SEROTYPE DIFFERENCES IN CELL TROPISM
    GERBER, SI
    BELVAL, BJ
    HEROLD, BC
    VIROLOGY, 1995, 214 (01) : 29 - 39
  • [28] Rapid-Release Griffithsin Fibers for Dual Prevention of HSV-2 and HIV-1 Infections
    Tyo, Kevin M.
    Lasnik, Amanda B.
    Zhang, Longyun
    Jenson, Alfred B.
    Fuqua, Joshua L.
    Palmer, Kenneth E.
    Steinbach-Rankins, Jill M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (06)
  • [29] Inhibition of herpes simplex virus type 2 (HSV-2) viral replication by the dominant negative mutant polypeptide of HSV-1 origin binding protein
    Yao, F
    Eriksson, E
    ANTIVIRAL RESEARCH, 2002, 53 (02) : 127 - 133
  • [30] Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
    Awasthi, Sita
    Hook, Lauren M.
    Pardi, Norbert
    Wang, Fushan
    Myles, Arpita
    Cancro, Michael P.
    Cohen, Gary H.
    Weissman, Drew
    Friedman, Harvey M.
    SCIENCE IMMUNOLOGY, 2019, 4 (39)